James Joseph Martin
CIK 1510224 · View on SEC EDGAR ↗
First SEC filing: Jan. 13, 2026 · Latest: Jan. 13, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2026 | COCP | A | 49,229 | — | — | 49,229 Direct | — | Acquired | (price as of 2026-08-25) |
| Oct. 28, 2025 | COCP | A | 3,598 | $1.39 | $5,001 | 44,167 Direct | +8.87% | Acquired | -20.1% (price as of 2026-08-25) |
| Oct. 28, 2025 | COCP | A | 7,196 | $1.39 | $10,002 | 7,196 Direct | — | Acquired | -20.1% (price as of 2026-08-25) |
| Oct. 9, 2024 | COCP | A | 40,000 | — | — | 40,569 Direct | +7029.88% | Acquired | (price as of 2026-08-25) |
| July 18, 2023 | COCP | A | 30,000 | — | — | 30,000 Direct | — | Acquired | (price as of 2026-08-25) |
| July 25, 2022 | COCP | A | 300,000 | — | — | 300,000 Direct | — | Acquired | (price as of 2026-08-25) |
| July 16, 2021 | COCP | A | 250,000 | — | — | 250,000 Direct | — | Acquired | (price as of 2026-08-25) |
| June 22, 2020 | COCP | A | 150,000 | — | — | 150,000 Direct | — | Acquired | (price as of 2026-08-25) |
| Sept. 21, 2018 | COCP | A | 150,000 | — | — | 150,000 Direct | — | Acquired | (price as of 2026-08-25) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 9, 2026 | COCP | Stock Options (Right to Buy) [F1] | Common Stock (49,229) | $1.10 | Jan. 9, 2036 | 49,229 | Acquired |
| Oct. 28, 2025 | COCP | Warrants [F1] | Common Stock (7,196) | $1.24 | Jan. 28, 2028 | 7,196 | Acquired |
| July 18, 2023 | COCP | Stock Options (Right to Buy) [F1] | Common Stock (30,000) | $2.67 | July 18, 2033 | 30,000 | Acquired |
| July 25, 2022 | COCP | Stock Options (Right to Buy) [F1] | Common Stock (300,000) | $0.42 | July 25, 2032 | 300,000 | Acquired |
| July 16, 2021 | COCP | Stock Options (Right to Buy) [F1] | Common Stock (250,000) | $1.11 | July 16, 2031 | 250,000 | Acquired |
| June 22, 2020 | COCP | Stock Options (Right to Buy) [F1] | Common Stock (150,000) | $1.33 | June 22, 2030 | 150,000 | Acquired |
| Sept. 21, 2018 | COCP | Stock Options (Right to Buy) [F1] | Common Stock (150,000) | $2.78 | Sept. 20, 2028 | 150,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $410,459 | $200,000 | $70,400 | — | — | — | — | $630,221 |
| 2023 | $394,821 | $165,000 | — | $67,380 | — | — | — | $627,201 |
| 2022 | $371,384 | $150,000 | — | $100,204 | — | — | — | $621,588 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.